Dr. Pillai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-218-5310
Summary
- I am a board-certified hematopathologist and molecular pathologist.
Education & Training
UPMC Medical EducationFellowship, Hematopathology, 2010 - 2012- UPMC Medical EducationFellowship, Molecular Genetic Pathology, 2009 - 2010
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pathology-Anatomic and Clinical, 2005 - 2009
Calicut Medical CollegeClass of 1993
Certifications & Licensure
CA State Medical License 2008 - 2026
PA State Medical License 2009 - 2016
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T cell lymphoma.Christiane Querfeld, Joycelynne M Palmer, Zhen Han, Xiwei Wu, Yate-Ching Yuan
Blood Advances. 2025-02-14 - Epstein-Barr virus-positive, primary cutaneous marginal zone lymphoma, with transformation: Case report and review of the literature.Lori Soma, Liliana Crisan, Jack Reid, Winston Lee, Joo Song
American Journal of Clinical Pathology. 2025-02-12 - Spatially distinct cellular and molecular landscapes define prognosis in triple negative breast cancer.Kavitha Mukund, Darya Veraksa, David Frankhouser, Lixin Yang, Jerneja Tomsic
Biorxiv. 2025-02-12
Journal Articles
- ERα-Mediated Cell Cycle Progression Is an Important Requisite for CDK4/6 Inhibitor Response in HR+ Breast CancerJoanne Mortimer, Laura Kruper, Raju Pillai, George Somlo, Yuan Yuan, Oncotarget
Abstracts/Posters
- Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular LymphomaRaju Pillai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Intralesional Administration of the CD47 Antagonist TTI-621 (SIRPαFc) Induces Responses in Both Injected and Non-Injected Lesions in Patients with Relapsed/Refractory ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
